FKBPL: a marker of good prognosis in breast cancer

FK506-binding protein-like (FKBPL) has established roles as an anti-tumor protein, with a therapeutic peptide based on this protein, ALM201, shortly entering phase I/II clinical trials. Here, we evaluated FKBPL's prognostic ability in primary breast cancer tissue, represented on tissue microarr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Laura, McKeen, Hayley D., Marshall, Andrea, Mulrane, Laoighse, Starczynski, Jane, Storr, Sarah J., Lanigan, Fiona, Byrne, Christopher, Arthur, Ken, Hegarty, Shauna, Ali, Ahlam Abdunnabi, Furlong, Fiona, McCarthy, Helen O., Ellis, Ian O., Green, Andrew R., Rakha, Emad, Young, Leonie, Kunkler, Ian, Thomas, Jeremy, Jack, Wilma, Cameron, David, Jirström, Karin, Yakkundi, Anita, McClements, Lana, Martin, Stewart G., Gallagher, William M., Dunn, Janet, Bartlett, John, O’Connor, Darran, Robson, Tracy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494933/
https://www.ncbi.nlm.nih.gov/pubmed/25906750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494933/
https://www.ncbi.nlm.nih.gov/pubmed/25906750

Ejemplares similares